Rossari Biotech Limited (ROSSARI) — Capital Reinvestment Ratio
Latest as of March 2025:
1.15x
Rossari Biotech Limited (ROSSARI) has a Capital Reinvestment Ratio of 1.15x as of March 2025, meaning it reinvests 1% of its operating cash flow (Rs1.37 Billion) in capital expenditures (Rs1.59 Billion). See free cash flow generation of Rossari Biotech Limited to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.15x
Capex / Operating Cash Flow
Operating Cash Flow
Rs1.37 Billion
INR
Capital Expenditures
Rs1.59 Billion
INR
Data as of
Mar 2025
Most recent filing
Rossari Biotech Limited Capital Reinvestment Ratio (2017–2025)
This chart tracks Rossari Biotech Limited's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Rossari Biotech Limited (2017–2025)
Year-by-year Capital Reinvestment Ratio for Rossari Biotech Limited from 2017 to 2025. For live market cap and broader valuation context, see Rossari Biotech Limited (ROSSARI) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.15x | Rs1.37 Billion | Rs1.59 Billion | ▼ -62.0% |
| 2024 | 3.04x | Rs432.55 Million | Rs1.31 Billion | ▲ +1306.9% |
| 2023 | 0.22x | Rs1.52 Billion | Rs328.76 Million | ▼ -83.4% |
| 2022 | 1.30x | Rs293.58 Million | Rs382.25 Million | ▲ +7.1% |
| 2021 | 1.22x | Rs477.67 Million | Rs580.84 Million | ▼ -12.2% |
| 2020 | 1.39x | Rs548.28 Million | Rs759.71 Million | ▲ +124.2% |
| 2019 | 0.62x | Rs711.77 Million | Rs439.91 Million | ▲ +13.5% |
| 2018 | 0.54x | Rs255.69 Million | Rs139.25 Million | ▼ -34.6% |
| 2017 | 0.83x | Rs46.95 Million | Rs39.12 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow